CURSARO, CARMELA
 Distribuzione geografica
Continente #
NA - Nord America 2.329
AS - Asia 1.365
EU - Europa 744
SA - Sud America 178
AF - Africa 44
Continente sconosciuto - Info sul continente non disponibili 26
OC - Oceania 2
Totale 4.688
Nazione #
US - Stati Uniti d'America 2.249
SG - Singapore 417
CN - Cina 342
HK - Hong Kong 205
IT - Italia 189
BR - Brasile 143
VN - Vietnam 134
GB - Regno Unito 115
SE - Svezia 105
RU - Federazione Russa 86
BD - Bangladesh 67
KR - Corea 58
FI - Finlandia 51
DE - Germania 50
CA - Canada 42
FR - Francia 40
ID - Indonesia 31
IN - India 26
ZA - Sudafrica 19
MX - Messico 16
NL - Olanda 16
IQ - Iraq 15
BG - Bulgaria 14
ES - Italia 14
AR - Argentina 13
AT - Austria 10
PL - Polonia 9
UA - Ucraina 9
LT - Lituania 8
TR - Turchia 8
AE - Emirati Arabi Uniti 7
JP - Giappone 7
PK - Pakistan 7
CR - Costa Rica 6
IE - Irlanda 6
UZ - Uzbekistan 6
DZ - Algeria 5
EG - Egitto 5
SA - Arabia Saudita 5
CL - Cile 4
MA - Marocco 4
MY - Malesia 4
VE - Venezuela 4
AL - Albania 3
CH - Svizzera 3
CO - Colombia 3
CZ - Repubblica Ceca 3
EC - Ecuador 3
GE - Georgia 3
HN - Honduras 3
IL - Israele 3
JM - Giamaica 3
JO - Giordania 3
KZ - Kazakistan 3
PT - Portogallo 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BH - Bahrain 2
BO - Bolivia 2
GH - Ghana 2
KE - Kenya 2
KG - Kirghizistan 2
NI - Nicaragua 2
NP - Nepal 2
PE - Perù 2
PH - Filippine 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AM - Armenia 1
AU - Australia 1
AW - Aruba 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BS - Bahamas 1
BZ - Belize 1
CY - Cipro 1
DK - Danimarca 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
LK - Sri Lanka 1
MW - Malawi 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
TH - Thailandia 1
Totale 4.664
Città #
Santa Clara 312
Ashburn 265
Singapore 231
Hong Kong 198
Chandler 165
San Jose 163
Hefei 133
Council Bluffs 94
Nyköping 91
Fairfield 77
London 66
New York 57
Seoul 55
Los Angeles 52
Helsinki 51
Beijing 48
The Dalles 46
Hanoi 40
Houston 39
Ho Chi Minh City 38
Chicago 34
Seattle 34
Woodbridge 29
Milan 26
Wilmington 25
Buffalo 24
Jakarta 22
Boardman 20
Shanghai 19
Orem 18
São Paulo 18
Cambridge 16
Princeton 15
Ann Arbor 14
Dallas 14
Montreal 14
Salt Lake City 14
Frankfurt am Main 13
Phoenix 13
Moscow 12
Sofia 12
Amsterdam 11
Johannesburg 11
Lauterbourg 11
San Diego 11
Brooklyn 10
Rome 10
Toronto 10
Denver 9
Elk Grove Village 9
Manchester 9
Oakland 9
Warsaw 9
Haiphong 8
Kent 8
Redondo Beach 8
Boston 7
Naples 7
North Bergen 7
Paris 7
Portsmouth 7
Reggio Emilia 7
Dublin 6
Munich 6
Philadelphia 6
Secaucus 6
Tokyo 6
Atlanta 5
Boydton 5
Chennai 5
Mexico City 5
Modena 5
Poplar 5
Reading 5
Rio de Janeiro 5
San José 5
Tashkent 5
Washington 5
Alexandria 4
Bologna 4
Bremen 4
Changchun 4
Columbus 4
Dhaka 4
Dubai 4
Düsseldorf 4
Lahore 4
Mumbai 4
New Delhi 4
Ottawa 4
San Francisco 4
Stockholm 4
Baghdad 3
Belo Horizonte 3
Cairo 3
Campinas 3
Cavarzere 3
Cleveland 3
Curitiba 3
Da Nang 3
Totale 2.977
Nome #
Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: Final long-term results 275
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 274
Predictors of solid extra-hepatic non-skin cancer in liver transplant recipients and analysis of survival: a long-term follow-up study 254
Quality of life of hepatitis B virus surface antigen-positive patients with suppressed viral replication: comparison between inactive carriers and nucleot(s)ide analog-treated patients 222
Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis 219
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen-negative chronic hepatitis B genotype D 201
Quality of life in liver transplant recipients during the Corona virus disease 19 pandemic: A multicentre study 201
Virological Treatment Monitoring for Chronic Hepatitis B 199
Investigating Acute Hepatitis after SARS-CoV-2 Vaccination or Infection: A Genetic Case Series 197
Impact of interferon therapy on the natural history of hepatitis C virus related cirrhosis 195
Itching for Answers: A Comprehensive Review of Cholestatic Pruritus Treatments 192
Indomethacin increases 2′,5′-oligoadenylate synthetase release by cultured liver tissue of patients with HCV chronic active hepatitis 187
Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis B 185
Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels 177
Treatments for hbv: A glimpse into the future 177
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 175
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 171
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance 169
Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practice 166
Severe acute respiratory syndrome coronavirus-2-associated cholangiopathies 165
Interferon-α plus indomethacin combined therapy in HBeAg positive chronic hepatitis B non-responder to a previous IFNα course: Results of a pilot study 158
Preliminary results of thymosin-α1 versus IFN-α treatment in patients with HBeAg negative and HBV-DNA positive chronic active hepatitis 153
6. A randomized controlled trial of leukocytic IFN-a vs leukocytic IFN-a plus ribavirin in chronic hepatitis C resistant to a previous recombinant or lymphoblastoid IFN treatment 139
Worsening of Serum Lipid Profile after Direct Acting Antiviral Treatment 125
Diagnostic Performance of PIVKA-II in Italian Patients with Hepatocellular Carcinoma 112
Totale 4.688
Categoria #
all - tutte 23.598
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.598


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022176 0 0 0 2 4 16 4 34 22 22 36 36
2022/2023442 47 55 45 48 38 56 12 52 68 0 12 9
2023/2024295 11 18 10 39 63 33 20 36 10 7 19 29
2024/20251.132 30 6 4 65 205 156 98 67 170 94 90 147
2025/20262.008 139 87 135 245 300 152 199 99 233 186 131 102
2026/2027450 85 163 119 83 0 0 0 0 0 0 0 0
Totale 4.688